Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REFLEX: Rituximab in RA with inadequate anti-TNF response
NCT00468546Phase 3Completed
- Sponsor
- Roche
- Start
- May 2003
- Primary completion
- Jan 2005
- Modality
- Monoclonal Antibodies
- Countries
- 11
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Started May 2003; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00468546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00468546.